All In MedTech

FDA Clearance Tracker · P970003-S170

VNS THERAPY SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 12, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 12, 2016

Approved

Time to decision

655 days

Received Apr 28, 2014. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P970003-S170
Device name
VNS THERAPY SYSTEM
Applicant location
Houston, TX
Received
Apr 28, 2014
Decided
Feb 12, 2016
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P970003

Device type

Device class
Class III

Every decision under product code MUZ

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at Cyberonics Latam S.L.R., Edificio B49, 51 Ave 0, Zona Franca Coyol, Coyol - Alajuela, Costa Rica facility, in which the site will perform the final assembly, packaging, storing, and distribution of the Implantable Pulse Generators and the Lead Finals.

Source documents

Other decisions for LivaNova USA, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

4 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.